| ANRIL | Antisense non-coding RNA in the INK4 locus |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A |
| CNF | Cutaneous neurofibroma |
| CpG | Cytosine–phosphate–guanine |
| CRE | cAMP response element |
| DNA | Deoxyribonucleic acid |
| EED | Embryonic ectoderm development |
| ERK | Extracellular signal-regulated kinase |
| H3K27me3 | Trimethylation of lysine 27 on histone H3 |
| HGAP | High-grade astrocytomas with piloid features |
| HOX | Homeobox |
| KDM4 | Lysine demethylase 4 |
| KDM6 | Lysine demethylase 6 |
| LncRNA | Long non-coding RNA |
| MAP2K3 | Mitogen-activated protein kinase 3 |
| MEK | Mitogen-activated protein kinase |
| MET | MET proto-oncogene, receptor tyrosine kinase |
| miRNA | MicroRNA |
| MKK3 | Mitogen-activated protein kinase 3 |
| MLH1 | MutL homolog 1 |
| MMP2 | Matrix metalloproteinase 2 |
| MPNST | Malignant peripheral nerve sheath tumour |
| mRNA | Messenger ribonucleic acid |
| MSH2 | MutS homolog 2 |
| MSH6 | MutS homolog 6 |
| MSP | Methylation-specific PCR |
| ncRNA | Non-coding RNA |
| NF-CAR | Neurofibromatosis consensus area of regulation |
| NF1 | Neurofibromatosis type 1 |
| NF1HCS | NF1 5′ highly conserved sequence |
| NF2 | Neurofibromatosis type 2 |
| NF2-SWN | NF2-related schwannomatosis |
| p53 | Tumour suppressor p53 |
| PCR | Polymerase chain reaction |
| PMEPA1 | Prostate transmembrane protein, androgen induced 1 |
| PMS2 | Postmeiotic segregation increased 2 |
| PNF | Plexiform neurofibroma |
| PRC2 | Polycomb repressive complex 2 |
| RAS | Rat sarcoma virus oncogene |
| RASSF1A | Ras association domain family member 1 isoform A |
| RNA | Ribonucleic acid |
| rs2151280 | Reference SNP ID 2151280 |
| SAM | S-adenosylmethionine |
| SK-ES-1 | Human Ewing sarcoma cell line |
| SNP | Single-nucleotide polymorphism |
| SP1 | Specificity protein 1 |
| SUZ12 | Suppressor of zeste 12 |
| TALGN | Transgelin |
| TF | Transcription factor |
| U-251 MG cells | Uppsala 251 Malignant Glioma cells |
| UTR | Untranslated region |
| VS | Vestibular schwannoma |